Tech stocks once again led the market lower on Wednesday as the difficult 2022 for Wall Street continued. But bad news in the market for ETF investors is good news for ETF short sellers.
The second-quarter reporting season is upon us, and the second quarter has been a tricky one for companies to navigate. COVID lockdowns in China – a nation often called the "world's factory," the war in Ukraine and skyrocketing inflation served as recipes for a looming disaster.
Twitter Inc (NYSE: TWTR) has a “strong iron fist upper hand” in the legal fight set to play out in a Delaware court after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said he was terminating a deal
UBS initiated coverage on customer engagement platform Braze Inc (NASDAQ: BRZE) on Monday.
What Happened: The analyst firm initiated coverage on Braze with a Buy rating and announced a $53 price target.
Raymond James initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Strong Buy rating and $29 price target (68% upside) and Dyne Therapeutics Inc (NASDAQ:DYN)…
BMO Capital Markets downgraded MacroGenics Inc (NASDAQ:MGNX) to Market Perform following the discontinuation of enoblituzumab (B7H3 antibody) for head and neck cancers. The…
BMO Capital Market upgraded Fate Therapeutics Inc (NASDAQ:FATE) to Outperform from Market Perform. The analyst believes Fate’s iPSC platform is uniquely positioned…